Abdel-GAbbar, M. et al. 2022. Effectiveness of Ombitasvir with Paritaprevir/Ritonavir plus Ribavirin on the Treatment of Naïve Patients with Chronic Hepatitis C Virus Genotype 4. Iraqi Journal of Pharmaceutical Sciences. 31, 1 (Jun. 2022), 57–64. DOI:https://doi.org/10.31351/vol31iss1pp57-64.